Increasing Surgical Processes in the World Are Driving the Growth of the Global Lidocaine Ointment Market
Lidocaine Ointment Market |
Lidocaine
Ointment Market, by Formulation (Internal Use and Topical Use), by Age Group
(Children and Adults), by Application (Insect Bite, Sun Burn, Minor Cut, Mouth
Sore, and Others), by Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, and Online Pharmacies), by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and
Opportunity Analysis, 2022 - 2030.
Market Overview:
Lidocaine
ointment is a topical medication that contains the active ingredient lidocaine,
which is a local anesthetic. It is used for temporary pain relief and numbing
of the skin and mucous membranes. Lidocaine works by blocking nerve signals in
the area where it is applied, thereby reducing pain sensations.
Competitive Landscape:
Major
players operating in the Global
Lidocaine Ointment Market include SEPTODONT, Inc., Zuche
Pharmaceuticals Private Limited., Quagen Pharmaceuticals, Zydus Healthcare
Limited., Sandoz AG, Aspen Pharmacare Australia Pty Ltd., Hi-Tech
Pharmaceuticals, Liberty Pharmaceuticals, Inc., Ascend Laboratories LLC,
Alembic Pharmaceuticals Limited, Amneal Pharmaceuticals LLC., Novocol Pharma,
ASTRAZENECA CANADA INC., Neon Laboratories Ltd., CENTURA PHARMACEUTICALS INC.,
Taro Pharmaceutical Industries Ltd., Teligent Inc., and Glenmark
Pharmaceuticals U.S. Inc.
Key Market Drivers:
Chronic
pain conditions, such as arthritis, neuropathy, and back pain, affect a
significant portion of the global population. Lidocaine ointment offers a
convenient and non-invasive option for localized pain relief, leading to
increased demand for such products. This is expected to augment the growth of
the global lidocaine ointment market. For instance, according to the National
Institutes of Health (NIH), around 310 million surgeries are performed every
year in the world.
The
global geriatric population is increasing, resulting in a higher prevalence of
age-related conditions that cause pain and discomfort. Lidocaine ointment is
widely used among the elderly for managing localized pain associated with
arthritis, joint stiffness, and muscle soreness.
There
is a growing awareness and acceptance of topical analgesics, including lidocaine
ointment, as an alternative to oral pain medications. Topical application
provides targeted relief and avoids systemic side effects often associated with
oral medications. This is estimated to enhance the growth of the global
lidocaine ointment market.
Covid-19 Impact Analysis:
The
COVID-19 pandemic led to a significant disruption in elective medical
procedures, including dermatological and surgical procedures that often require
lidocaine ointment for local anesthesia. This resulted in a temporary decline
in the demand for lidocaine ointment in some regions. This restrained the
growth of the global lidocaine ointment market.
Key Takeaways:
·
North America is
expected to dominate the growth of the global Lidocaine
Ointment Market. The region benefits from a well-established healthcare
infrastructure, a high prevalence of chronic pain conditions, and strong
consumer awareness regarding the availability and benefits of topical
analgesics. For instance, according to the National Institutes of Health (NIH),
around 50 million surgeries are performed every year in the United States.
·
Europe is estimated to
witness high growth in the global Lidocaine
Ointment Market. Countries such as Germany, the United Kingdom, and
France have a growing geriatric population, leading to increased demand for
pain management solutions. The presence of key market players and advanced
healthcare facilities also contributes to market growth. For instance,
according to the National Institutes of Health (NIH), around 20 million
surgeries are performed every year in Europe.
Comments
Post a Comment